JonAKobashigawaMD

Adult Congenital Heart Disease, Cardiac Electrophysiology, Heart Failure & Transplantation

Clinical Professor of Medicine, UCLA

Dr. Kobashigawa is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
127 S San Vicente Blvd
# A3107
Los Angeles, CA 90048
Phone+1 310-248-3830

Fax+1 310-248-8338

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 1984 - 1986
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1980 - 1983
Icahn School of Medicine at Mount SinaiClass of 1980
Stanford UniversityB.S., 1972 - 1976

Fellow (FAHA) American Heart Association
Fellow (FACC) American College of Cardiology
Co-Chair, Thoracic Community of Practice Committee American Society for Transplantation
Past President International Society for Heart and Lung Transplantation
Past Chair American College Cardiology, Heart Failure and Transplantation Committee
Past Member UNOS National Thoracic Committee
Executive Program Committee World Transplant Congress, 2014
America's Top Doctors Castle Connolly, 2002-2014
Top Doctors:LA Area Castle Connolly, 2013
Top Doctors:Southern California Castle Connolly, 2012
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Join now to see all

PubMed

3 citations
U.S. Donor Heart Allocation Bias for Men Over Women?: A Closer Look∗
Jon A. Kobashigawa
JACC. Heart Failure. 2014-08-01
9 citations
Statistical performance of 16 posttransplant risk scores in a contemporary cohort of heart transplant recipients
Guillaume Coutance, Evan P. Kransdorf, Guillaume Bonnet, Alexandre Loupy, Jon A. Kobashigawa
American Journal of Transplantation. 2021-02-01
40 citations
Donor heart selection: Evidence-based guidelines for providers.
Hannah Copeland, Ivan Knezevic, David A Baran, Vivek Rao, Michael Pham
The Journal of Heart and Lung Transplantation. 2023-01-01

Journal Articles

Omission of Heart Transplant Recipients from the Appropriate Use Criteria for Revascularization and the Ramifications on Heart Transplant Centers
Jon A Kobashigawa, Steven W Tabak, Wendy Book, John A Spertus, JAMA Cardiology
Non‐Invasive Detection of Graft Injury After Heart Transplantation Using Donor‐Derived Cell‐Free DNA: A Prospective Multi‐Center Study
Gregory Ewald, Jon Kobashigawa, Kiran K Khush, Jignesh Patel, Eugene DePasquale, Sean Pinney, American journal of transplantation
Oxford University Press Has Registered This DOI Pre-Publication
Michelle Kittleson, Heidi Reich, Lawrence Czer, Dominick Megna, Jignesh Patel, Fardad Esmailian, Jon Kobashigawa, Oxford University Press
Use of Durable Mechanical Circulatory Support on Outcomes of Heart–Kidney Transplantation
Jon A Kobashigawa, Jaime Moriguchi, Joshua L Chan, Francisco Arabia, Fardad Esmailian, Dominick Megna, Lawrence S Czer, Interactive CardioVascular and Thoracic Surgery
Join now to see all

Lectures

CAV at 50 What We Know and What We Don't
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
State-of-the-Art Review Imaging in Heart Transplant Patients
Cedars Sinai Medical Center, Riverside, California - 9/15/2012

Omission of Heart Transplant Recipients from the Appropriate Use Criteria for Revascularization and the Ramifications on Heart Transplant CentersApril 2020
Temporal Trends of De Novo Malignancy Development After Heart TransplantationJanuary 2018
Temporal Trends of De Novo Malignancy Development After Heart TransplantationJanuary 2018
Temporal Trends of De Novo Malignancy Development After Heart TransplantationJanuary 2018
Join now to see all

Smidt Heart Institute Experts Available for Interviews During ISHLT ConferenceApril 18th, 2023
ISHLT Honors Jon Kobashigawa for Lifetime Achievement in Treating Advanced Heart DiseaseFebruary 15th, 2023
Upcoming Life Sciences EventsMay 3rd, 2022
Join now to see all